New drugs for cystic fibrosis patients in Scotland

Child with cystic fibrosis in a hospital bed

Image copyright
Getty Images

Image caption

Cystic fibrosis is a life-shortening genetic condition causes fatal lung damage and affects about 900 people in Scotland

Two “life-changing” cystic fibrosis drugs are to be made available to 400 patients in Scotland a month after their use was rejected by the NHS.

Pharmaceutical company Vertex has announced it has signed a five-year deal with the Scottish government.

Orkambi and Symkevi were rejected for routine use by NHS Scotland in August.

The drugs help improve lung health in patients with cystic fibrosis, but were to cost about £100,000 per year per patient.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *